Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryon Johnson

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Frontiers in Immunology|December 11, 2023
Cancer chemoprevention with PV-1, a novel <i>Prunella vulgaris</i>-containing herbal mixture that remodels the tumor immune microenvironment in miceQi Zhang, Xu Chen, Katie Palen, et al.
Anticancer Research|October 15, 2010
Increased expression of macrophage migration inhibitory factor during progression to hypopharyngeal squamous cell carcinomaStéphanie Cludts, Christine Decaestecker, Bryon Johnson, et al.
Stem Cells (Dayton, Ohio)|June 17, 2015
p38γ MAPK Is a Therapeutic Target for Triple-Negative Breast Cancer by Stimulation of Cancer Stem-Like Cell ExpansionXiaomei Qi, Ning Yin, Shao Ma, et al.
Ebiomedicine|November 5, 2019
Potentiation of Kras peptide cancer vaccine by avasimibe, a cholesterol modulatorJing Pan, Qi Zhang, Katie Palen, et al.
BMC Cancer|March 29, 2018
Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment modelsSusan Tsai, Laura McOlash, Katie Palen, et al.
Haematologica|October 6, 2022
Associations between socioeconomic status and bispecific LV20.19 CAR T-cell therapy outcomesJennifer M Knight, Edward Hackett, Aniko Szabo, et al.
NPJ Precision Oncology|October 25, 2023
Striking efficacy of a vaccine targeting TOP2A for triple-negative breast cancer immunopreventionSang Beom Lee, Jing Pan, Donghai Xiong, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 9, 2019
A Phase 2 Study of Pembrolizumab during Lymphodepletion after Autologous Hematopoietic Cell Transplantation for Multiple MyelomaAnita D'Souza, Parameswaran Hari, Marcelo Pasquini, et al.
Blood Advances|December 6, 2021
Unrelated donor α/β T cell- and B cell-depleted HSCT for the treatment of pediatric acute leukemiaAllison Barz Leahy, Yimei Li, Julie-An Talano, et al.
Communications Medicine|May 23, 2022
Patient-reported outcomes and neurotoxicity markers in patients treated with bispecific LV20.19 CAR T cell therapyJennifer M Knight, Aniko Szabo, Igli Arapi, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|December 11, 2023
Cancer chemoprevention with PV-1, a novel <i>Prunella vulgaris</i>-containing herbal mixture that remodels the tumor immune microenvironment in miceQi Zhang, Xu Chen, Katie Palen, et al.
Anticancer Research|October 15, 2010
Increased expression of macrophage migration inhibitory factor during progression to hypopharyngeal squamous cell carcinomaStéphanie Cludts, Christine Decaestecker, Bryon Johnson, et al.
Stem Cells (Dayton, Ohio)|June 17, 2015
p38γ MAPK Is a Therapeutic Target for Triple-Negative Breast Cancer by Stimulation of Cancer Stem-Like Cell ExpansionXiaomei Qi, Ning Yin, Shao Ma, et al.
Ebiomedicine|November 5, 2019
Potentiation of Kras peptide cancer vaccine by avasimibe, a cholesterol modulatorJing Pan, Qi Zhang, Katie Palen, et al.
BMC Cancer|March 29, 2018
Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment modelsSusan Tsai, Laura McOlash, Katie Palen, et al.
Haematologica|October 6, 2022
Associations between socioeconomic status and bispecific LV20.19 CAR T-cell therapy outcomesJennifer M Knight, Edward Hackett, Aniko Szabo, et al.
NPJ Precision Oncology|October 25, 2023
Striking efficacy of a vaccine targeting TOP2A for triple-negative breast cancer immunopreventionSang Beom Lee, Jing Pan, Donghai Xiong, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 9, 2019
A Phase 2 Study of Pembrolizumab during Lymphodepletion after Autologous Hematopoietic Cell Transplantation for Multiple MyelomaAnita D'Souza, Parameswaran Hari, Marcelo Pasquini, et al.
Blood Advances|December 6, 2021
Unrelated donor α/β T cell- and B cell-depleted HSCT for the treatment of pediatric acute leukemiaAllison Barz Leahy, Yimei Li, Julie-An Talano, et al.
Communications Medicine|May 23, 2022
Patient-reported outcomes and neurotoxicity markers in patients treated with bispecific LV20.19 CAR T cell therapyJennifer M Knight, Aniko Szabo, Igli Arapi, et al.
Pageof 3